Publication | Open Access

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

Her2 StatusBreast OncologyMedicineAdjuvant Tamoxifen TherapyPharmacologyGynecologyBreast CancerEgf ReceptorCancer TreatmentOncologyRadiation OncologyEndocrine-related Cancer